Real World Evidence: Expectations, Outcomes, Pitfalls | Saama Technologies

Real World Evidence: Expectations, Outcomes, Pitfalls

Use cases from Big Pharma and how to get started

On-demand webcast

Real World Evidence


Sign up to get the on-demand recording of this webinar featuring Sissi Pham, Danny Yeh, and Nikhil Gopinath—experts on Health Economics Outcomes Research, Market Access, and RWE Data Analytics—as they explore:

  • How Big Pharma leverage RWE for registration, business development, product differentiation, and payer collaborations.
  • Common pitfalls of RWE initiatives and challenges that prevent full utilization of RWE.
  • How today's technologies can address some of the challenges of utilizing massive, disparate real world data sets.

Sissi Pham

Sissi Pham

Previously Regional Director
Global Health Outcome
GlaxoSmithKline

Sissi Pham

Sissi began her career with GlaxoSmithKline in the UK. By the end of her tenure, she managed the global and health outcomes and market access support function based in the US. She is experienced in designing and implementing frameworks for robust Market Access strategies, timely and relevant evidence generation plan, and effective communication of Market Access information. Sissi has also served on the benefits working group of the Pharmaceutical Research and Manufacturers of America that built a general framework for translating medical benefits into new stakeholder-centric value propositions during drug development. In addition, she has served as the Institutional Council Chair for the International Society of Pharmaceutical Outcomes Research, where she initiated the development of a supplement reviewing trends in health technology assessments (HTA) around the world that was published in the May 2009 edition of Value in Health. This publication has contributed to the comparative effectiveness dialogue in the US and the evolution of HTA. Sissi has an appointment of Associate Clinical Professor at the College of Pharmacy, University of Arizona. Sissi’s Market Access experiences were acquired through her career experiences in pharmacoeconomics fellowship, pharmaceutical industry health outcomes research and market support functions, and strategic market access consulting.

Danny Yeh

Danny Yeh

Previously Associate Director
Global Market Access
Biogen 

Danny Yeh

Danny Yeh PhD, was the former head of Center for Observational Research Analytics, a center of excellence for real-world evidence, at Biogen. Danny is a health economist by training and has strong expertise in observational research and economic modeling. In his career, Danny served as HEOR lead for drug development programs across disease areas. He leveraged real-world data to support business development, clinical development, product differentiation, health technology assessment, and outcomes-based contracting.

Nikhil Gopinath

Nikhil Gopinath

Sr. Solutions Engineer
Life Sciences
Saama 

Nikhil Gopinath

Nikhil Gopinath is a Senior Solutions Engineer & Life Sciences Practice Lead for Saama Technologies. His focus comprises of big data architecture and design, data integration, applications of data science in clinical development, and visual analytics. With a background in clinical research and product development of organic nanoparticle conjugate vaccines, Nikhil applies his diverse skill-sets to build data-driven solutions from pre-clinical to post-launch across the entire drug development continuum.

Nikhil currently partners with organizations to provide innovative approaches and transform business processes. He has earned his B.S. in Biochemistry from North Carolina State University and is currently pursuing a Master's in Biomedical Informatics at Rutgers University.